Why The Clorox Company (CLX) Stock Is Up Today

The Clorox Company (CLX) is up 3.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued momentum from Clorox’s better-than-expected fiscal first-quarter results and its decision to keep full-year sales and adjusted EPS guidance in place. A recent open-market purchase by a board member may also be reinforcing investor confidence. This could also be because money has been rotating toward more defensive consumer staples names.

Details:

Clorox reported fiscal Q1 2027 adjusted EPS of $1.55, up sharply from the prior-year quarter, while net sales rose 33% and organic sales increased 18%.

Management said first-quarter performance was better than expected, helped by strong execution and timing benefits, even though input-cost inflation remained a headwind.

The company maintained its fiscal 2027 outlook for net sales growth of 13% to 14% and adjusted EPS of $5.70 to $6.00, though it now expects results near the low end because of higher costs.

An SEC Form 4 filed on November 5 showed director Pierre Breber bought 4,000 shares at about $100.06 each on November 4, a roughly $400,000 open-market purchase.

Sources:

The Clorox Company, SEC, AP News

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CLX Insider Trading Activity

$CLX insiders have traded $CLX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CLX stock by insiders over the last 6 months:

PIERRE R BREBER purchased 4,000 shares for an estimated $400,250

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CLX Hedge Fund Activity

We have seen 490 institutional investors add shares of $CLX stock to their portfolio, and 598 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BEUTEL, GOODMAN & CO LTD. added 2,012,569 shares (+inf%) to their portfolio in Q3 2026, for an estimated $163,038,214
POINT72 ASSET MANAGEMENT, L.P. removed 1,592,288 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $151,967,966
MILLENNIUM MANAGEMENT LLC added 1,381,163 shares (+199.6%) to their portfolio in Q2 2026, for an estimated $131,818,196
INVESCO LTD. added 1,150,832 shares (+23.7%) to their portfolio in Q2 2026, for an estimated $109,835,406
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,137,006 shares (+inf%) to their portfolio in Q2 2026, for an estimated $108,515,852
UBS GROUP AG added 1,066,071 shares (+116.6%) to their portfolio in Q2 2026, for an estimated $101,745,816
WORLDQUANT MILLENNIUM ADVISORS LLC added 820,913 shares (+inf%) to their portfolio in Q2 2026, for an estimated $78,347,936

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CLX Congressional Stock Trading

Members of Congress have traded $CLX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CLX stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/15.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.